Logitech Q1 Beats, Boosts Revenue Outlook; Bullish Stance On Verrica Pharma
- July 25th, 2023
- 387 views
Logitech International S.A. (Nasdaq: LOGI) announced its first-quarter fiscal 2024 results, with earnings per share (EPS) of $0.65 and revenue of $974.5 million, surpassing the consensus estimate of $0.46 on revenue of $919.69 million.
Following this strong performance, Logitech has raised its outlook for the first half of Fiscal Year 2024. The company now expects revenue to be in the range of $1.875 billion to $1.975 billion, up from the previous range of $1.8 billion to $1.9 billion.
$LOGI is trading at $65.80 in pre-market, reflecting an increase of $2.84 (+4.51%).
In other news, Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a pharmaceutical company focused on developing medical solutions for various skin conditions, received a notable upgrade from Needham, who shifted its rating from Hold to Buy. In addition to the upgrade, Needham also announced a price target of $10.
Considering $VRCA closed at $5.11 on Monday, the stated price target suggests a potential upside of $4.89 or approximately 95.50% for $VRCA, as per the view of the brokerage firm.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login